Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;23(5):381.
doi: 10.3892/mmr.2021.12020. Epub 2021 Mar 24.

MicroRNA-124 facilitates lens epithelial cell apoptosis by inhibiting SPRY2 and MMP-2

Yan Liu #  1 , Shuting Li #  1 , Yao Liu  1 , Xujing Lv  1 , Qing Zhou  2
Affiliations

MicroRNA-124 facilitates lens epithelial cell apoptosis by inhibiting SPRY2 and MMP-2

Yan Liu et al. Mol Med Rep. 2021 May.

Abstract

Age-related cataract (ARC) is the primary cause of blindness worldwide. Abnormal expression of microRNAs (miRNAs/miRs) has been reported to be associated with multiple diseases, including ARC. However, the potential role of miR-124 in ARC remains unclear. The present study used the human lens epithelial cell line, SRA01/04, to investigate the potential role of miR-124 in ARC. Reverse transcription-quantitative PCR analysis was performed to detect the expression levels of miR-124, protein sprouty homolog 2 (SPRY2) and matrix metalloproteinase-2 (MMP-2) in ARC tissues, while western blotting was performed to detect the protein levels of SPRY2 and MMP-2. Cell viability and apoptosis of SRA01/04 cells were assessed via Cell Counting Kit-8 and TUNEL assays, respectively. The interaction between miR-124 and SPRY2 or MMP-2 was confirmed via the dual-luciferase reporter and RNA immunoprecipitation assays. The results of the present study demonstrated that miR-124 expression was significantly upregulated in ARC tissues, and knockdown of miR-124 increased SRA01/04 cell viability and suppressed apoptosis. In addition, SPRY2 and MMP-2 expression was decreased in ARC tissues, and were demonstrated to directly bind to miR-124. Overexpression of SPRY2 or MMP-2 increased SRA01/04 cell viability and repressed apoptosis, the effects of which were reversed following overexpression of miR-124. Taken together, these results suggested that miR-124 facilitates lens epithelial cell apoptosis by modulating SPRY2 or MMP-2 expression, providing a novel treatment approach for ARC.

Keywords: microRNA-124; protein sprouty homolog 2; matrix metalloproteinase-2; lens epithelial cells; age-related cataract.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1.
Figure 1.
miR-124 expression is increased in ARC tissues and miR-124 inhibitor inhibits SRA01/04 cells apoptosis. (A) RT-qPCR assay was performed to determine miR-124 expression in anterior lens capsules of ARC tissues compared with the normal tissues, n=28. (B) RT-qPCR assay was employed to measure miR-124 expression in SRA01/04 cells transfected with NC inhibitor or miR-124 inhibitor. (C) Cell Counting Kit-8 assay was used to evaluate cell viability in SRA01/04 cells transfected with miR-124 inhibitor or NC inhibitor. (D) TUNEL assay (magnification, ×200; scale bar, 50 µm) was performed to analyze cell apoptosis rate of SRA01/04 cells transfected with miR-124 inhibitor or NC inhibitor. *P<0.05 vs. control group. miR, microRNA; ARC, age-related cataract; RT-qPCR, reverse transcription-quantitative PCR; NC, negative control.
Figure 2.
Figure 2.
SPRY2 is a target of miR-124. (A) The binding sequence between miR-124 and SPRY2 was predicted using the StarBase website. (B) Dual-luciferase reporter assay showed the luciferase activity of SPRY2-wt or SPRY2-mut in SRA01/04 cells transfected with NC mimics or miR-124 mimics. (C) Dual-luciferase reporter assay showed the luciferase activity of SPRY2-wt or SPRY2-mut in SRA01/04 cells transfected with NC inhibitor or miR-124 inhibitor. (D) RIP assay showed the abundance of SPRY2 enriched by Ago2 or IgG in SRA01/04 cells transfected with NC mimics or miR-124 mimics. (E) RT-qPCR was performed to determine miR-124 expression in SRA01/04 cells transfected with miR-124 mimics or NC mimics. (F) RT-qPCR assay showed the expression of SPRY2 in SRA01/04 cells transfected with NC mimics, miR-124 mimics, NC inhibitor or miR-124 inhibitor. *P<0.05 vs. control group. miR, microRNA; RT-qPCR, reverse transcription-quantitative PCR; NC, negative control; SPRY2, protein sprouty homolog 2; wt, wild-type; mut, mutant; RIP, RNA immunoprecipitation; Ago2, argonaute 2; IgG, immunoglobin G.
Figure 3.
Figure 3.
miR-124 increases SRA01/04 cell apoptosis by targeting SPRY2. (A) RT-qPCR assay was employed to assess SPRY2 expression in ARC. (B) RT-qPCR and western blotting assays showed SPRY2 expression in SRA01/04 cells transfected with shSPRY2 or shNC. (C) CCK-8 assay showed the viability of SRA01/04 cells transfected with shSPRY2 or shNC. (D) TUNEL assay (magnification, ×200; scale bar, 50 µm) showed the apoptosis of SRA01/04 cells transfected with shSPRY2 or shNC. (E) RT-qPCR and western blotting assays showed SPRY2 expression in SRA01/04 cells transfected with pcDNA3.1/SPRY2 or pcDNA3.1. (F) CCK-8 assay showed the proliferation of SRA01/04 cells transfected with pcDNA3.1, pcDNA3.1/SPRY2, pcDNA3.1/SPRY2 + miR-124 mimics. (G) TUNEL assay (magnification, ×200; scale bar, 50 µm) showed the apoptosis of SRA01/04 cells transfected with pcDNA3.1, pcDNA3.1/SPRY2, pcDNA3.1/SPRY2 + miR-124 mimics. *P<0.05 vs. control group. miR, microRNA; RT-qPCR, reverse transcription-quantitative PCR; NC, negative control; SPRY2, protein sprouty homolog 2; sh-, short hairpin RNA; CCK-8, Cell Counting Kit-8; ARC, age-related cataract.
Figure 4.
Figure 4.
MMP-2 is targeted by miR-124. (A) The binding sequence between MMP-2 and miR-124 was predicted using StarBase software. (B) Dual-luciferase reporter assay showed the luciferase activity of MMP-2-wt or MMP-2-mut in SRA01/04 cells transfected with NC mimics or miR-124 mimics. (C) Dual-luciferase reporter assay showed the luciferase activity of MMP-2-wt or MMP-2-mut in SRA01/04 cells transfected with NC inhibitor or miR-124 inhibitor. (D) RIP assay showed the enrichment of MMP-2 by Ago2 or IgG in SRA01/04 cells transfected with NC mimics or miR-124 mimics. (E) Reverse transcription-quantitative PCR assay revealed MMP-2 expression in SRA01/04 cells transfected with NC mimics or miR-124 mimics, NC inhibitor or miR-124 inhibitor. *P<0.05. miR, microRNA; MMP-2, matrix metalloproteinase-2; wt, wild-type; mut, mutant; RIP, RNA immunoprecipitation; Ago2, argonaute 2; IgG, immunoglobin G; NC, negative control.
Figure 5.
Figure 5.
miR-124 depends on MMP-2 to regulate SRA01/04 cell apoptosis. (A) RT-qPCR was used to analyze MMP-2 expression in ARC tissues. (B) RT-qPCR and western blotting assays were performed to determine MMP-2 expression in SRA01/04 cells transfected with shMMP-2 or shNC. (C) CCK-8 assay showed the proliferation of SRA01/04 cells transfected with shMMP-2 or shNC. (D) TUNEL assay (magnification, ×200; scale bar, 50 µm) showed the cell apoptosis of SRA01/04 cells transfected with shMMP-2 or shNC. (E) RT-qPCR and western blotting assays were conducted to measure MMP-2 expression in SRA01/04 cells transfected with pcDNA3.1/MMP-2 or pcDNA3.1. (F) CCK-8 assay showed the proliferation of SRA01/04 cells transfected with pcDNA3.1, pcDNA3.1/MMP-2, pcDNA3.1/MMP-2 + miR-124 mimics. (G) TUNEL assay (magnification, ×200; scale bar, 50 µm) showed the apoptosis of SRA01/04 cells transfected with pcDNA3.1, pcDNA3.1/MMP-2, pcDNA3.1/MMP-2 + miR-124 mimics. *P<0.05 vs. control group. ARC, age-related cataract; miR, microRNA; RT-qPCR, reverse transcription-quantitative PCR; NC, negative control; MMP-2, matrix metalloproteinase-2; sh-, short hairpin RNA; CCK-8, Cell Counting Kit-8.
See this image and copyright information in PMC

References

    1. Nangia V, Jonas JB, George R, Lingam V, Ellwein L, Cicinelli MV, Das A, Flaxman SR, Keeffe JE, Kempen JH, et al. Vision Loss Expert Group of the Global Burden of Disease Study Prevalence and causes of blindness and vision impairment: Magnitude, temporal trends and projections in South and Central Asia. Br J Ophthalmol. 2019;103:871–877. doi: 10.1136/bjophthalmol-2018-312292. - DOI - PubMed
    1. Jin C, Chen X, Law A, Kang Y, Wang X, Xu W, Yao K. Different-sized incisions for phacoemulsification in age-related cataract. Cochrane Database Syst Rev. 2017;9:CD010510. - PMC - PubMed
    1. Tang Y, Wang X, Wang J, Huang W, Gao Y, Luo Y, Yang J, Lu Y. Prevalence of age-related cataract and cataract surgery in a Chinese adult population: The Taizhou Eye Study. Invest Ophthalmol Vis Sci. 2016;57:1193–1200. doi: 10.1167/iovs.15-18380. - DOI - PubMed
    1. Milazzo S, Grenot M, Benzerroug M. Posterior capsule opacification. J Fr Ophtalmol. 2014;37:825–830. doi: 10.1016/j.jfo.2014.09.003. (In French) - DOI - PubMed
    1. Mathias RT, White TW, Gong X. Lens gap junctions in growth, differentiation, and homeostasis. Physiol Rev. 2010;90:179–206. doi: 10.1152/physrev.00034.2009. - DOI - PMC - PubMed

MeSH terms